©The Author(s) 2026.
World J Methodol. Mar 20, 2026; 16(1): 106277
Published online Mar 20, 2026. doi: 10.5662/wjm.v16.i1.106277
Published online Mar 20, 2026. doi: 10.5662/wjm.v16.i1.106277
Table 3 Baseline characteristics of study population from included studies- blood parameters and comorbidities, n (%)
| Ref. | Serum albumin (g/dL) (mean ± SD) | Absolute neutrophil (109/L) (mean ± SD) | Absolute lymphocytes (109/L) (mean ± SD) | Leukocytes (109/L) (mean ± SD) | Neutrophil-to-lymphocyte ratio (mean ± SD) | Hemoglobin (g/dL) (mean ± SD) | C-reactive protein (mg/dL) (mean ± SD) | Cholesterol (mg/dL) (mean ± SD) | Diabetes mellitus |
| An et al[19] | 3.9 ± 0.5 | 5.0 ± 1.7a | 1.5 ± 0.5a | N/A | 3.33 ± 3.4 | 100.2 ± 20.3 | 1.3 ± 0.9a | 216.6 ± 58 | 33 (23.9) |
| Liu et al[18] | 3.7 ± 0.5 | N/A | N/A | 6.6 ± 0.52 | 2.87 ± 0.3 | 101 ± 21 | N/A | 189 ± 11 | 449 (25.3) |
| Zeng et al[17] | 3.5 ± 0.5a | 4.1 ± 1.6a | 1.2 ± 0.52a | 6.1 ± 2.0a | 3.3 ± 1.5a | 8.7 ± 1.9a | N/A | 162.4 ± 42.9 | 342 (22.8) |
| Zhang et al[16] | 3.5 ± 5 | 4.4 ± 2.1a | 1.4 ± 0.6a | 6.5 ± 2.4a | 2.87 ± 0.4 | 8.8 ± 2.2 | 3.15 ± 1.7 | 162.02 ± 44.9 | 31 (22) |
| Xu et al[15] | 3 ± 0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Lau et al[14] | 3.5 ± 0.4 | 4.6 ± 2.0a | 1.1 ± 0.4a | 6.6 ± 2.2a | 3.9 ± 3.06a | 8.9 ± 1.3 | 0.41 ± 0.3 | N/A | 115 (51.1) |
| Liu[13] | 3 ± 0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
- Citation: Damarlapally N, Vempati R, Mourad D, Vasudevan SS, Mathur G, Khan A, Banda P, Polamarasetty H, Chauhan S, Manjappachar N, Bhatti T, Desai R. Association of neutrophil-lymphocyte ratio with all-cause and cardiovascular mortality in peritoneal dialysis patients: A systematic review and meta-analysis. World J Methodol 2026; 16(1): 106277
- URL: https://www.wjgnet.com/2222-0682/full/v16/i1/106277.htm
- DOI: https://dx.doi.org/10.5662/wjm.v16.i1.106277